Cargando…
The Diagnostic Performance of DCE-MRI in Evaluating the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis
Background: Neoadjuvant chemotherapy (NAC) is commonly utilized in preoperative treatment for local breast cancer, and it gives high clinical response rates and can result in pathologic complete response (pCR) in 6–25% of patients. In recent years, dynamic contrast-enhanced magnetic resonance imagin...
Autores principales: | Cheng, Qingqing, Huang, Jiaxi, Liang, Jianye, Ma, Mengjie, Ye, Kunlin, Shi, Changzheng, Luo, Liangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028702/ https://www.ncbi.nlm.nih.gov/pubmed/32117747 http://dx.doi.org/10.3389/fonc.2020.00093 |
Ejemplares similares
-
Predictive value of DCE-MRI and IVIM-DWI in osteosarcoma patients with neoadjuvant chemotherapy
por: Xia, Xibin, et al.
Publicado: (2022) -
Monitoring Treatment Efficacy of Antiangiogenic Therapy Combined With Hypoxia-Activated Prodrugs Online Using Functional MRI
por: Ma, Mengjie, et al.
Publicado: (2021) -
Pretreatment DCE-MRI-Based Deep Learning Outperforms Radiomics Analysis in Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Peng, Yunsong, et al.
Publicado: (2022) -
Deep learning radiomic analysis of DCE-MRI combined with clinical characteristics predicts pathological complete response to neoadjuvant chemotherapy in breast cancer
por: Li, Yuting, et al.
Publicado: (2023) -
3T DCE-MRI Radiomics Improves Predictive Models of Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Montemezzi, Stefania, et al.
Publicado: (2021)